Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Freeby

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Current Opinion in Endocrinology, Diabetes, and Obesity|December 17, 2020
Adjunctive therapies in type 1 diabetes mellitusKyrstin Lane, Matthew Freeby
Current Opinion in Endocrinology, Diabetes, and Obesity|October 11, 2023
Treating obesity in type 1 diabetes mellitus - review of efficacy and safetyMatthew Freeby, Kyrstin Lane
Current Opinion in Endocrinology, Diabetes, and Obesity|November 17, 2022
Type 2 diabetes mellitus and cognitive function: understanding the connectionsLisa Dao, Sarah Choi, Matthew Freeby
Islets|December 11, 2012
Vesicular monoamine transporter, type 2 (VMAT2) expression as it compares to insulin and pancreatic polypeptide in the head, body and tail of the human pancreasMatthew Freeby, Masanori Ichise, Paul E Harris
BMJ Open Quality|August 19, 2025
Identifying facilitators, barriers and areas of opportunity in diabetic retinopathy screening: quality improvement through qualitative methodsSenxi Du, Matthew Freeby, Maria Han, et al.
BMJ Case Reports|October 6, 2017
Anti-PD-L1 therapy and the onset of diabetes mellitus with positive pancreatic autoantibodiesJennifer Way, Alexandra Drakaki, Andrew Drexler, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 1, 2007
VMAT2 gene expression and function as it applies to imaging beta-cell massPaul E Harris, Caterina Ferrara, Pasquale Barba, et al.
Journal of Diabetes|December 31, 2019
Prefrontal cortex brain damage and glycemic control in patients with type 2 diabetesSarah E Choi, Bhaswati Roy, Matthew Freeby, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|June 3, 2026
Population-Level Teleretinal Screening Bulk Orders to Improve Diabetic Retinopathy Screening Rates: A Randomized Quality Improvement TrialSarah W Takimoto, Matthew Freeby, Maria Han, et al.
Molecular Endocrinology (Baltimore, Md.)|August 24, 2012
Dopamine-mediated autocrine inhibitory circuit regulating human insulin secretion in vitroNorman Simpson, Antonella Maffei, Matthew Freeby, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Opinion in Endocrinology, Diabetes, and Obesity|December 17, 2020
Adjunctive therapies in type 1 diabetes mellitusKyrstin Lane, Matthew Freeby
Current Opinion in Endocrinology, Diabetes, and Obesity|October 11, 2023
Treating obesity in type 1 diabetes mellitus - review of efficacy and safetyMatthew Freeby, Kyrstin Lane
Current Opinion in Endocrinology, Diabetes, and Obesity|November 17, 2022
Type 2 diabetes mellitus and cognitive function: understanding the connectionsLisa Dao, Sarah Choi, Matthew Freeby
Islets|December 11, 2012
Vesicular monoamine transporter, type 2 (VMAT2) expression as it compares to insulin and pancreatic polypeptide in the head, body and tail of the human pancreasMatthew Freeby, Masanori Ichise, Paul E Harris
BMJ Open Quality|August 19, 2025
Identifying facilitators, barriers and areas of opportunity in diabetic retinopathy screening: quality improvement through qualitative methodsSenxi Du, Matthew Freeby, Maria Han, et al.
BMJ Case Reports|October 6, 2017
Anti-PD-L1 therapy and the onset of diabetes mellitus with positive pancreatic autoantibodiesJennifer Way, Alexandra Drakaki, Andrew Drexler, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 1, 2007
VMAT2 gene expression and function as it applies to imaging beta-cell massPaul E Harris, Caterina Ferrara, Pasquale Barba, et al.
Journal of Diabetes|December 31, 2019
Prefrontal cortex brain damage and glycemic control in patients with type 2 diabetesSarah E Choi, Bhaswati Roy, Matthew Freeby, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|June 3, 2026
Population-Level Teleretinal Screening Bulk Orders to Improve Diabetic Retinopathy Screening Rates: A Randomized Quality Improvement TrialSarah W Takimoto, Matthew Freeby, Maria Han, et al.
Molecular Endocrinology (Baltimore, Md.)|August 24, 2012
Dopamine-mediated autocrine inhibitory circuit regulating human insulin secretion in vitroNorman Simpson, Antonella Maffei, Matthew Freeby, et al.
Pageof 3